Which hedge funds own ALLO? ALLOGENE THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in ALLO (ALLOGENE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $68.9m in total. The largest holder by portfolio weight is Woodline Partners at 0.0% of its book. 2 exited: Point72 Asset Management LP, Tudor Investment.
8tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold ALLO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.0% | $9.4m | 4,500,624 | 29% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $21.0m | 10,087,770 | 48% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $8.0m | 3,834,312 | 79% | added |
| Marshall Wace | Q2 2026 | 0.0% | $10.6m | 5,095,408 | 48% | added |
| Millennium Management | Q2 2026 | 0.0% | $10.1m | 4,843,889 | 46% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $9.8m | 4,710,735 | 70% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $81.2k | 39,018 | -37% | reduced |
| Horizon Kinetics | Q2 2026 | 0.0% | $34.9k | 16,776 | -5% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Point72 Asset Management LP | 0.0% | $540.1k |
| Tudor Investment | 0.0% | $175.9k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of ALLO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $68.9m |
| Q1 2026 | 10 | $54.5m |
| Q4 2025 | 5 | $8.1m |
| Q3 2025 | 4 | $9.1m |
| Q2 2025 | 4 | $6.9m |
| Q1 2025 | 4 | $8.8m |
| Q4 2024 | 4 | $10.9m |
| Q3 2024 | 4 | $14.7m |
| Q2 2024 | 5 | $15.5m |
| Q1 2024 | 5 | $15.9m |
| Q4 2023 | 5 | $14.5m |
| Q3 2023 | 5 | $18.8m |
| Q2 2023 | 6 | $28.2m |
| Q1 2023 | 5 | $13.2m |
| Q4 2022 | 3 | $21.6m |
| Q3 2022 | 4 | $53.5m |
Counts every tracked manager that disclosed ALLO in that quarter's filing, including managers that have since stopped filing.